Eptifibatide plus alteplase rendered recanalised canine coronary arteries resistant to platelet recruitment

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1426, 2004-01, pp. : 19-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Platelet Glycoprotein IIb/IIIa Inhibitors in Percutaneous Coronary Intervention: Focus on the Pharmacokinetic-Pharmacodynamic Relationships of Eptifibatide

By Gilchrist I.C.

Clinical Pharmacokinetics, Vol. 42, Iss. 8, 2003-01 ,pp. : 703-720

Adis International

Access to resources Recommend Favorite

Clopidogrel + eptifibatide CLEARs PLATELETS after coronary stenting

Inpharma, Vol. 1, Iss. 1480-1481, 2005-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Eptifibatide cost effective for acute coronary disorders

Inpharma, Vol. 1, Iss. 1326, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Eptifibatide cost-effective option for coronary interventions

Inpharma, Vol. 1, Iss. 1310, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Eptifibatide `highly cost-effective' for coronary stenting

Inpharma, Vol. 1, Iss. 1315, 2001-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite